Ensign Peak Advisors
ITCI

Ensign Peak Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Ensign Peak Advisors’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-29,562
Closed -$2.47M – 1736
2024
Q4 		$2.47M Buy
29,562
+1,298
+5% +$107K ﹤0.01% 849
2024
Q3 		$2.07M Sell
28,264
-13,373
-32% -$1.01M ﹤0.01% 931
2024
Q2 		$2.85M Sell
41,637
-100,000
-71% -$6.94M 0.01% 784
2024
Q1 		$9.8M Buy
141,637
+98,574
+229% +$6.78M 0.02% 456
2023
Q4 		$3.08M Hold
43,063
– – 0.01% 754
2023
Q3 		$2.24M Sell
43,063
-825
-2% -$48.1K ﹤0.01% 800
2023
Q2 		$2.78M Hold
43,888
– – 0.01% 762
2023
Q1 		$2.38M Buy
43,888
+16,948
+63% +$819K 0.01% 781
2022
Q4 		$1.43M Buy
26,940
+2,600
+11% +$130K ﹤0.01% 942
2022
Q3 		$1.13M Sell
24,340
-101,153
-81% -$5.28M ﹤0.01% 1005
2022
Q2 		$7.16M Sell
125,493
-9,060
-7% -$514K 0.02% 438
2022
Q1 		$8.23M Buy
134,553
+11,226
+9% +$583K 0.02% 470
2021
Q4 		$6.46M Buy
123,327
+39,067
+46% +$1.64M 0.01% 592
2021
Q3 		$3.14M Buy
84,260
+12,463
+17% +$433K 0.01% 859
2021
Q2 		$2.93M Hold
71,797
– – 0.01% 899
2021
Q1 		$2.44M Hold
71,797
– – 0.01% 1010
2020
Q4 		$2.28M Buy
71,797
+43,806
+157% +$1.15M 0.01% 985
2020
Q3 		$718K Buy
+27,991
New +$639K ﹤0.01% 1435

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Ensign Peak Advisors's ITCI Position: Q1 2025 in Review

Ensign Peak Advisors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 29,562 shares — an estimated $2.47M sold.

Ensign Peak Advisors first reported a position in ITCI in Q3 2020 and held it in 18 quarters. The position peaked at $9.8M in Q1 2024. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • Ensign Peak Advisors reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • Ensign Peak Advisors sold 29,562 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $2.47M.
  • Ensign Peak Advisors first reported a position in Intra-Cellular Therapies Inc. in Q3 2020 and held it in 18 quarters.
  • Ensign Peak Advisors's Intra-Cellular Therapies Inc. position peaked at $9.8M in Q1 2024.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on Ensign Peak Advisors's 13F filing for Q1 2025, filed 14 May 2025.